FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944065197> ?p ?o ?g. }

• W2944065197 endingPage "354" @default.
• W2944065197 startingPage "350" @default.
• W2944065197 abstract "To assess the long-term effectiveness of pirfenidone in idiopathic pulmonary fibrosis (IPF) treatment and to establish its adverse effects profile.Retrospective observational study in patients with IPF who initiated treatment with pirfenidone between 2011 and 2016. We collected demographic variables (age, sex); date of first and last treatment; reason for discontinuation; pulmonary function measures (forced vital capacity (FVC), carbon monoxide diffusion capacity (DLCO), and 6 min walk test (6MWT)) at treatment initiation (baseline) and at 1, 2 and 3 year follow-up; adherence to pirfenidone treatment; recorded adverse effects; and mortality.Thirty-one patients treated with pirfenidone were included; mean±SD age was 69±8 years, 74% were men, and 59% had a smoking history. Mean baseline values were: FVC 2.43±0.66 L (61.8±12.1%); DLCO 46.1±19.4%; and 6MWT 334±125 m. Median duration of treatment was 14±13 months, and treatment was discontinued in 58% of patients. The most frequently observed adverse effects were gastrointestinal disturbances and photosensitivity. Twenty (65%) patients were evaluated at 1 year, when mean FVC was 2.41±0.86 L (64.7±20.3%); DLCO 50.8±26.8%; and 6MWT 341±139 m. At 2 years' follow-up, 11 patients (36%) who were still taking pirfenidone were evaluated. Mean FVC was 2.34±0.79 L (66.2±14.7%); DLCO 50.0±28.3%; and 6MWT 265±121 m. At 3 years, five patients were still taking the treatment. Mean FVC was 2.71±0.84 L (71.0±24.7%); DLCO 52.6±26.7%; and 6MWT 286±139 m. Nineteen per cent of patients were non-adherent to treatment.Pirfenidone seems to be effective for long-term control of IPF despite substantial variability in response among individual patients. The most frequent adverse effects were digestive and cutaneous, prompting in some cases a reduction in dose or even discontinuation of the treatment." @default.
• W2944065197 created "2019-05-16" @default.
• W2944065197 creator A5005447120 @default.
• W2944065197 creator A5015498239 @default.
• W2944065197 creator A5055952764 @default.
• W2944065197 creator A5057737365 @default.
• W2944065197 creator A5062255355 @default.
• W2944065197 creator A5082046714 @default.
• W2944065197 creator A5090991298 @default.
• W2944065197 date "2019-05-07" @default.
• W2944065197 modified "2023-09-26" @default.
• W2944065197 title "Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis" @default.
• W2944065197 cites W1569431722 @default.
• W2944065197 cites W1938547050 @default.
• W2944065197 cites W1954728404 @default.
• W2944065197 cites W1965854265 @default.
• W2944065197 cites W2004697839 @default.
• W2944065197 cites W2013280721 @default.
• W2944065197 cites W2045756883 @default.
• W2944065197 cites W2057292199 @default.
• W2944065197 cites W2095309945 @default.
• W2944065197 cites W2096828977 @default.
• W2944065197 cites W2098305693 @default.
• W2944065197 cites W2101548854 @default.
• W2944065197 cites W2104766198 @default.
• W2944065197 cites W2117488044 @default.
• W2944065197 cites W2125013258 @default.
• W2944065197 cites W2167383172 @default.
• W2944065197 cites W2168666423 @default.
• W2944065197 cites W2295461102 @default.
• W2944065197 cites W2319711690 @default.
• W2944065197 cites W2510319197 @default.
• W2944065197 cites W2510494560 @default.
• W2944065197 cites W2597638604 @default.
• W2944065197 cites W2748660768 @default.
• W2944065197 cites W2754271091 @default.
• W2944065197 cites W2770650876 @default.
• W2944065197 cites W2802310648 @default.
• W2944065197 cites W2803426914 @default.
• W2944065197 cites W4296612182 @default.
• W2944065197 doi "https://doi.org/10.1136/ejhpharm-2018-001806" @default.
• W2944065197 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7856155" @default.
• W2944065197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33020058" @default.
• W2944065197 hasPublicationYear "2019" @default.
• W2944065197 type Work @default.
• W2944065197 sameAs 2944065197 @default.
• W2944065197 citedByCount "6" @default.
• W2944065197 countsByYear W29440651972020 @default.
• W2944065197 countsByYear W29440651972021 @default.
• W2944065197 countsByYear W29440651972022 @default.
• W2944065197 crossrefType "journal-article" @default.
• W2944065197 hasAuthorship W2944065197A5005447120 @default.
• W2944065197 hasAuthorship W2944065197A5015498239 @default.
• W2944065197 hasAuthorship W2944065197A5055952764 @default.
• W2944065197 hasAuthorship W2944065197A5057737365 @default.
• W2944065197 hasAuthorship W2944065197A5062255355 @default.
• W2944065197 hasAuthorship W2944065197A5082046714 @default.
• W2944065197 hasAuthorship W2944065197A5090991298 @default.
• W2944065197 hasBestOaLocation W29440651972 @default.
• W2944065197 hasConcept C126322002 @default.
• W2944065197 hasConcept C141071460 @default.
• W2944065197 hasConcept C16020263 @default.
• W2944065197 hasConcept C165637977 @default.
• W2944065197 hasConcept C197934379 @default.
• W2944065197 hasConcept C2777714996 @default.
• W2944065197 hasConcept C2778341716 @default.
• W2944065197 hasConcept C2778715236 @default.
• W2944065197 hasConcept C2779832356 @default.
• W2944065197 hasConcept C3018587741 @default.
• W2944065197 hasConcept C55520419 @default.
• W2944065197 hasConcept C71924100 @default.
• W2944065197 hasConcept C75603125 @default.
• W2944065197 hasConceptScore W2944065197C126322002 @default.
• W2944065197 hasConceptScore W2944065197C141071460 @default.
• W2944065197 hasConceptScore W2944065197C16020263 @default.
• W2944065197 hasConceptScore W2944065197C165637977 @default.
• W2944065197 hasConceptScore W2944065197C197934379 @default.
• W2944065197 hasConceptScore W2944065197C2777714996 @default.
• W2944065197 hasConceptScore W2944065197C2778341716 @default.
• W2944065197 hasConceptScore W2944065197C2778715236 @default.
• W2944065197 hasConceptScore W2944065197C2779832356 @default.
• W2944065197 hasConceptScore W2944065197C3018587741 @default.
• W2944065197 hasConceptScore W2944065197C55520419 @default.
• W2944065197 hasConceptScore W2944065197C71924100 @default.
• W2944065197 hasConceptScore W2944065197C75603125 @default.
• W2944065197 hasIssue "6" @default.
• W2944065197 hasLocation W29440651971 @default.
• W2944065197 hasLocation W29440651972 @default.
• W2944065197 hasLocation W29440651973 @default.
• W2944065197 hasLocation W29440651974 @default.
• W2944065197 hasOpenAccess W2944065197 @default.
• W2944065197 hasPrimaryLocation W29440651971 @default.
• W2944065197 hasRelatedWork W1547683341 @default.
• W2944065197 hasRelatedWork W2045756883 @default.
• W2944065197 hasRelatedWork W2146324716 @default.
• W2944065197 hasRelatedWork W2340104373 @default.
• W2944065197 hasRelatedWork W2411042954 @default.
• W2944065197 hasRelatedWork W2555155415 @default.

• next